Gene Therapy and Genomic Editing: Understanding Basic Concepts

By WIRB-Copernicus Group
Published: September 2017

Recent advances in recombinant DNA technology—especially CRISPR techniques—have raised public interest in the potential for genome editing. This paper provides a brief background to help better understand the roles of gene therapy and genome editing in clinical trials and pharmaceutical development. 

Please enter in your information below. Fields with an * are required.

Please enter a valid email address to receive an email with a link to download the white paper.   

The WIRB-Copernicus Group® (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research.